Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

W. Chen (Oxford, United Kingdom), C. Hardman (Oxford, United Kingdom), P. Batty (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), Y. Wu (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), D. Sandham (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland)

Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Session: Studies on the mechanisms underlying airway disease
Session type: Thematic Poster
Number: 4401
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Chen (Oxford, United Kingdom), C. Hardman (Oxford, United Kingdom), P. Batty (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), Y. Wu (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), D. Sandham (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland). Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s). 4401

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prostaglandin E2 suppresses the function of human group 2 innate lymphoid cells
Source: International Congress 2018 – Roles of innate lymphoid cells in asthma
Year: 2018


The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells
Source: Eur Respir J 2003; 22: Suppl. 45, 100s
Year: 2003

Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


The up-regulation of cysteinyl-leukotriene receptors on T cells
Source: Eur Respir J 2003; 22: Suppl. 45, 395s
Year: 2003

5-Hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of human dendritic cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009


Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019


Fevipiprant antagonises prostaglandin D2-induced activation of type-2 CD8 T cells (Tc2)
Source: International Congress 2019 – Novel targets and mechanisms in asthma
Year: 2019




Serotonin (5-hydroxytryptamine) modulates cytokine and chemokine production in lipopolysaccharide-primed human monocytes via stimulation of different 5-HT receptor subtypes
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


Generation and activation of myeloid derived suppressor cells using prostaglandin E2 and EP receptor agonists in vitro
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019


Fevipiprant is superior to montelukast in suppressing type 2 cytokine production from mast cell stimulated human Th2 cells
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019




AMP affects intracellular Ca2+ signalling, migration, cytokine secretion and T-cell priming capacity of human dendritic cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009


Over-expression of SIGIRR attenuates TLR 4,5,9-mediated immune responses in human airway epithelial cells
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Central role for phosphoinositide-3-kinase gamma/delta dependent signalling in eosinophilic pulmonary inflammation driven by innate lymphoid cells
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017

Toll-like receptors in human T lymphocytes: altered expression during tonsillar inflammation
Source: Eur Respir J 2005; 26: Suppl. 49, 223s
Year: 2005

Differential toll-like receptor (TLR) responses of primary human alveolar macrophages and type II epithelial (AT2) cells alone and in co-culture
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009

GB001 potently inhibits PGD2 metabolite-induced DP2-mediated cell signaling and eosinophil activation
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020


Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages
Source: Eur Respir J 2007; 29: 986-994
Year: 2007



Human CD40 ligand-expressing type 3 innate lymphoid cells induce interleukin (IL)-10-producing immature transitional regulatory B-cells
Source: International Congress 2018 – Roles of innate lymphoid cells in asthma
Year: 2018


The muscarinic receptors promote IL-8 release in airway epithelial cells via the pERK42/44 and NF-kB pathways
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006

Tc1 cells increase after allergen stimulation and inhibit Th2 cell activation: a case study
Source: Eur Respir J 2001; 18: Suppl. 33, 273s
Year: 2001